ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

‘Butterfly Boy’ steels himself for second stem-cell transplant – Ottawa Citizen

Continue reading

2017-03-11 Michael Zand NEWS

Combination immunotherapy effective for advanced prostate cancer – Science Daily

Combination immunotherapy effective for advanced prostate cancerScience DailyCombination immunotherapy effective for advanced prostate cancer. Date: March 9, 2017; Source: University of Texas M. D. Anderson Cancer Center; Summary: Advanced prostate can… Continue reading

2017-03-11 Michael Zand NEWS

CAR T-Cell Therapy Has High Response Rate in Non-Hodgkin Lymphoma – Curetoday.com

Curetoday.comCAR T-Cell Therapy Has High Response Rate in Non-Hodgkin LymphomaCuretoday.comJCAR017, a CAR T-cell therapy, had a high objective response rate (80 percent), including a complete response rate of 60 percent for patients with relapsed or re… Continue reading

2017-03-11 Michael Zand NEWS

Preview: Immunotherapy – CBS News


Ottawa Citizen

‘Butterfly Boy’ steels himself for second stem–cell transplant
Ottawa Citizen
Bracing for his second stem–cell transplant in seven months, Jonathan Pitre knows all too well the mountain in front of him, its hardships and precipices. So he’s doing what he always does when confronted with such a steep challenge. “It’s all about …

Continue reading

2017-03-11 Michael Zand NEWS

How are Stem Cells Regulated? – Multiple Sclerosis News Today

Multiple Sclerosis News TodayHow are Stem Cells Regulated?Multiple Sclerosis News TodayStem cells, like other therapies intended to treat, cure, or prevent disease, require U.S. Food and Drug Administration (FDA) approval before they can be marketed. … Continue reading

2017-03-11 Michael Zand NEWS

aHSCT – Autologous Hemopoietic Stem Cell Transplantation in MS – Multiple Sclerosis News Today


CBS News

Preview: Immunotherapy
CBS News
March 11, 2017, 1:29 PM | Dr. Jon LaPook introduces us to the next frontier of cancer treatment: Immunotherapy, in which the body’s own immune system is modified to fight cancer. Don’t miss his report on “Beyond Cancer,” a special broadcast of “Sunday …
Dr. Jon LaPook Hosts ‘Beyond Cancer’ Edition of CBS Sunday …TVNewser
‘CBS Sunday Morning,’ CNN offer health specials – Orlando SentinelOrlando Sentinel
Exploring new frontiers in cancer treatmentYahoo News

all 6 news articles »

Continue reading

2017-03-11 Michael Zand NEWS

Morning Rounds: Arthritis, immunotherapy and strokes – CBS News


Multiple Sclerosis News Today

aHSCT – Autologous Hemopoietic Stem Cell Transplantation in MS
Multiple Sclerosis News Today
After immunoablation is complete, the collected stem cells are then re-infused to reconstitute the immune system and re-activate it. The intended result of the therapy is to return the immune system to a functional state so that the body’s autoimmune …

Continue reading

2017-03-11 Michael Zand NEWS

OHSU gene therapy studies offer hope – and vision – to patients with eye disease – KATU


CBS News

Morning Rounds: Arthritis, immunotherapy and strokes
CBS News
Also: CBS News chief medical correspondent Dr. Jon LaPook also previews his “Sunday Morning” report on immunotherapy, which harnesses the body’s own immune system to find and destroy cancer cells; and CBS News contributor Dr. Tara Narula reports …

and more »

Continue reading

2017-03-11 Michael Zand NEWS
  • 1
  • …
  • 1,990
  • 1,991
  • 1,992
  • 1,993
  • 1,994
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

OHSU gene therapy studies offer hope – and vision – to patients with eye disease
KATU
Rods we use at nighttime and in dim light, cones are what we use during the daytime and for our color vision, says Dr. Mark Pennesi, OHSU Associate Professor of Ophthalmology who’s now treating Bretana for the disease with gene therapy.